Immunome Inc
NASDAQ:IMNM
Immunome Inc
NASDAQ:IMNM
Price:
24
USD
-9.13%
Market Closed
Market Cap:
$2.2B
Cash Flow Statement
Cash Flow Statement
Immunome Inc
Immunome Inc
Currency: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(11)
|
(17)
|
(18)
|
(22)
|
(22)
|
(21)
|
(25)
|
(32)
|
(36)
|
(37)
|
(37)
|
(30)
|
(26)
|
(22)
|
(107)
|
(232)
|
(263)
|
(305)
|
(293)
|
(205)
|
(212)
|
(223)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
0
|
0
|
1
|
1
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
7
|
9
|
13
|
16
|
19
|
21
|
23
|
|
| Other Non-Cash Items |
0
|
6
|
6
|
6
|
7
|
2
|
3
|
4
|
5
|
5
|
6
|
33
|
29
|
25
|
87
|
187
|
197
|
212
|
166
|
58
|
56
|
49
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
2
|
(1)
|
(1)
|
(2)
|
1
|
3
|
7
|
5
|
2
|
2
|
(2)
|
1
|
(0)
|
12
|
2
|
4
|
5
|
15
|
(8)
|
(25)
|
(13)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(9)
-2%
|
(12)
-40%
|
(16)
-29%
|
(16)
-1%
|
(17)
-10%
|
(18)
-4%
|
(21)
-16%
|
(25)
-21%
|
(29)
-14%
|
(29)
+0%
|
2
N/A
|
4
+129%
|
3
-25%
|
(8)
N/A
|
(43)
-467%
|
(61)
-41%
|
(86)
-42%
|
(111)
-29%
|
(153)
-38%
|
(179)
-17%
|
(185)
-4%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(38)
|
(47)
|
(52)
|
(54)
|
(26)
|
(18)
|
(13)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(30)
|
0
|
(102)
|
(72)
|
(32)
|
(17)
|
(7)
|
88
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
+2%
|
(1)
+2%
|
(1)
-5%
|
(0)
+66%
|
(0)
+43%
|
(0)
+33%
|
(0)
+25%
|
(0)
-267%
|
(0)
+14%
|
(0)
-32%
|
(0)
-40%
|
(1)
-49%
|
(1)
-6%
|
(30)
-5 443%
|
(68)
-122%
|
(149)
-120%
|
(125)
+16%
|
(85)
+32%
|
(43)
+50%
|
(25)
+41%
|
75
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
16
|
16
|
56
|
56
|
73
|
73
|
29
|
29
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
6
|
26
|
22
|
21
|
67
|
|
| Net Issuance of Debt |
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(6)
|
0
|
(6)
|
(6)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
61
|
116
|
332
|
331
|
270
|
215
|
161
|
161
|
160
|
|
| Cash from Financing Activities |
16
N/A
|
15
-3%
|
50
+228%
|
50
+0%
|
66
+32%
|
67
+1%
|
28
-59%
|
28
0%
|
0
-98%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
61
+202 933%
|
116
+91%
|
336
+188%
|
337
+0%
|
276
-18%
|
241
-13%
|
183
-24%
|
183
0%
|
228
+25%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
7
N/A
|
6
-9%
|
37
+522%
|
34
-9%
|
50
+48%
|
49
-1%
|
9
-81%
|
7
-30%
|
(25)
N/A
|
(29)
-16%
|
(29)
+1%
|
2
N/A
|
4
+145%
|
64
+1 586%
|
78
+23%
|
225
+188%
|
127
-44%
|
65
-49%
|
45
-31%
|
(12)
N/A
|
(21)
-76%
|
117
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(9)
N/A
|
(9)
-2%
|
(13)
-38%
|
(16)
-28%
|
(16)
+1%
|
(18)
-9%
|
(18)
-4%
|
(21)
-15%
|
(26)
-21%
|
(29)
-13%
|
(29)
+0%
|
2
N/A
|
4
+148%
|
3
-29%
|
(8)
N/A
|
(81)
-863%
|
(107)
-33%
|
(139)
-29%
|
(164)
-18%
|
(179)
-9%
|
(197)
-10%
|
(198)
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
